March 28, 2017
A drug pricing watchdog group had its final say Friday on targeted arthritis treatments – and it may not be good news for patients.
March 24, 2017
A vaccine for Zika virus is in the works with the potential to halt the devastating disease that’s spread to more than 5,000 people and 1,600 pregnant women in the United States alone. But before the drug is even available, a political debate is heating up – not over the drug’s development and accessibility, but over speculation about its future price tag.
February 21, 2017
The Institute for Clinical and Economic Review’s newest cost-effectiveness report underscores just how far economic modeling sometimes diverges from patients’ reality, explained the Institute for Patient Access in a February 17 letter. The report analyzes rheumatoid arthritis treatments’ value by modeling expenses for simulated patients over a lifetime on certain treatments.
January 24, 2017
New guidance from the Food and Drug Administration directs companies on how to demonstrate a biosimilar’s interchangeability with its reference product.
January 16, 2017
The names of biologic and biosimilar medicines will include randomly generated four-letter suffixes, the Food and Drug Administration announced Thursday.
January 12, 2017
News on Tuesday that President-elect Donald Trump may form a federal panel on vaccine safety prompted outcry from physicians and advocates.
December 16, 2016
Hepatitis C patients keep waiting…and waiting…and waiting.
December 13, 2016
A new position paper from the European Crohn’s and Colitis Organisation has garnered attention from physicians and patient advocates across Europe.
December 12, 2016
f policymakers get it right, biosimilars could offer more safe and effective treatment options for patients in the coming years – potentially at lower costs.
November 16, 2016
The Food and Drug Administration may not have reached consensus on the suffixes that distinguish biological and biosimilar medications, but physicians are of one mind: Meaningful suffixes matter.
